chr5-69433088-C-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The ENST00000325631.10(MARVELD2):​c.1498C>T​(p.Arg500Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00027 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00029 ( 0 hom. )

Consequence

MARVELD2
ENST00000325631.10 stop_gained

Scores

4
2
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 2.97
Variant links:
Genes affected
MARVELD2 (HGNC:26401): (MARVEL domain containing 2) The protein encoded by this gene is a membrane protein found at the tight junctions between epithelial cells. The encoded protein helps establish epithelial barriers such as those in the organ of Corti, where these barriers are required for normal hearing. Defects in this gene are a cause of deafness autosomal recessive type 49 (DFNB49). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-69433088-C-T is Pathogenic according to our data. Variant chr5-69433088-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1198.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-69433088-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MARVELD2NM_001038603.3 linkuse as main transcriptc.1498C>T p.Arg500Ter stop_gained 5/7 ENST00000325631.10 NP_001033692.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MARVELD2ENST00000325631.10 linkuse as main transcriptc.1498C>T p.Arg500Ter stop_gained 5/71 NM_001038603.3 ENSP00000323264 P1Q8N4S9-1

Frequencies

GnomAD3 genomes
AF:
0.0000860
AC:
13
AN:
151152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000660
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000995
AC:
25
AN:
251192
Hom.:
0
AF XY:
0.000110
AC XY:
15
AN XY:
135792
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000202
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000289
AC:
423
AN:
1461488
Hom.:
0
Cov.:
34
AF XY:
0.000260
AC XY:
189
AN XY:
727060
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000188
Gnomad4 NFE exome
AF:
0.000369
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.0000860
AC:
13
AN:
151152
Hom.:
0
Cov.:
32
AF XY:
0.0000136
AC XY:
1
AN XY:
73636
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000660
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000967
Hom.:
0
Bravo
AF:
0.000121
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive nonsyndromic hearing loss 49 Pathogenic:5
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteMay 06, 2021Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Deafness 49 (MIM#610153). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (26 heterozygotes, 0 homozygotes). (SP) 0701 - Many NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar, PMID: 23767834, 33597575). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been previously reported as pathogenic in individuals with hearling loss (ClinVar, PMID: 17186462, 31850270) (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 01, 2006- -
Likely pathogenic, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesAug 07, 2018- -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJul 29, 2023- -
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaNov 30, 2018The MARVELD2 c.1498C>T (p.Arg500Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Arg500Ter variant is reported in a homozygous state in eight individuals from one family with nonsyndromic hearing loss (Riazuddin et al. 2006). The p.Arg500Ter variant was shown to segregate with the disease and was absent from 443 normal hearing subjects matched for ethnicity. The p.Arg500Ter variant is reported at a frequency of 0.00024 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies showed that the p.Arg500Ter variant disrupts the binding of the occludin domain to the scaffolding protein ZO-1 (Riazuddin et al. 2006). Nayak et al. (2013) generated knockin mice that were homozygous for the p.Arg500Ter variant and demonstrated ultrastructural changes in the tricellular junctions in all sensory and nonsensory epithelia of the inner ear organs and cochlear hair cell loss. Vax-Drago et al. (2015) demonstrated that, in a cell line derived from an individual who was homozygous for the p.Arg500Ter variant, total cellular mRNA levels were reduced compared to wild type, especially in the cytoplasmic fraction. Based on the evidence and the potential impact of stop-gained variants, the p.Arg500Ter variant is classified as pathogenic for autosomal recessive nonsyndromic hearing loss. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxJan 27, 2023Published functional studies demonstrate that this variant results in disrupted MARVELD2 ZO-1 binding capacity, mislocalization of the protein from the tricellular junctions, and non-specific targeting of the mutant protein to basolateral domains of transfected cells (Nayak et al., 2013; Nayak et al., 2015); Nonsense variant in the C-terminus predicted to result in protein truncation, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 17186462, 25666562, 25652404, 25525159, 28705832, 29752989, 30406641, 31850270, 31589614, 26226137, 23979167) -
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 19, 2014The p.Arg500X variant in MARVELD2 has been previously reported in one individual with hearing loss and segregated with disease in 7 affected relatives from one family (Riazuddin 2006). It has also been identified in 0.018% (23/126596) of E uropean chromosomes by gnomAD (http://gnomad.broadinstitute.org). This nonsense variant creates a premature termination codon at position 500 and is predicted t o lead to a truncated or absent protein. Functional and animal studies support t he pathogenicity of the p.Arg500X variant (Riazuddin 2006, Nayak 2013). In summa ry, this variant meets criteria to be classified as pathogenic for autosomal rec essive sensorineural hearing loss. ACMG/AMP Criteria applied: PM3_Supporting, P P1_Strong, PVS1, PS3. -
Ear malformation Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingKariminejad - Najmabadi Pathology & Genetics CenterJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.43
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
37
DANN
Uncertain
1.0
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Uncertain
0.91
D
MutationTaster
Benign
1.0
A;A;A;A
Vest4
0.86, 0.85, 0.66
GERP RS
4.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs118203957; hg19: chr5-68728915; API